Human iPSC-Derived Ventricular Cardiomyocytes (Male)

Axol Bioscience

Human iPSC-Derived Ventricular Cardiomyocytes (Male)

9

Cardiac Cells

Research Use Only

axoCells Human iPSC-Derived Ventricular Cardiomyocytes (≥1 million cells) for cardiovascular research. Ventricular cardiomyocytes made from iPSCs generated from a 74 year old male donor's pulmonary fibroblasts.Key highlights include:• Spontaneously beat 3 days post-thaw and assay-ready in just 7 days• Validated against all 28 CiPA compounds• Demonstrate functional responses in a range of assay formats including patch clamp, electrophysiology and voltage-sensitive dyesThey are frequently used to fuel in vitro cardiotoxicity models to assess drug safety and for cardiac research. They can also be used in co-culture with other cells (including atrial cardiomyocytes).

41116155